Citoyen
  • Home
  • Feed

Explore

  • Countries
  • Categories
  • Compare
  • My follows

Understand

  • BriefingsBy country and category
  • Deep divesIn-depth analyses
  • Track recordsEach leader's record
  • ReformsTracker and simulators

Data

  • Sources
  • Calendar

Citoyen

  • About
  1. World
  2. ›
  3. Health

Health: who gets the most for their money?

The United States spends nearly twice as much per person on health as France, with worse results. Asia gets a lot for little. And is the French model, whose national insurance pushes prices down, as efficient as it is said to be? What OECD and WHO figures show.

Citoyen·Data as of Nov 14, 2026

Scope: OECD countries plus China, India, Brazil, Indonesia, South Africa, Russia, Saudi Arabia, Argentina and Singapore; OECD health accounts, WHO health expenditure database (via the World Bank), latest year published for each country.

This deep dive is updated at least once a quarter with the new figures. Follow it to get a notification at each update.

Key points

Health spending per person, United States$13,062in 2022, against $6,761 in France (purchasing-power-parity dollars)
Deaths avoidable through care, United States95 per 100,000per 100,000 people in 2022, against 48 per 100,000 in France
Administration cost per person, United States relative to France×2.9in 2024; drugs: ×2.1
Share paid directly by patients, France9.3%in 2023, among the lowest; 31.8% in Korea
  • The United States spends the most, for worse results. In 2022, an American costs $13,062 of care, 1.9 times a French person ($6,761). Yet deaths that effective care should have avoided are twice as frequent there (95 per 100,000 per 100,000 people, against 48 per 100,000), and life expectancy (78.4 years) is close to China’s (78.0 years).
  • The American extra cost comes mostly from prices and administration (evidence level C). Americans spend 2.1 times more than the French on drugs and 2.9 times more on running insurance per person, while comparative studies find they do not use more care.
  • France is efficient compared with the United States, less so compared with Asia and southern Europe. Its treatable mortality (48 per 100,000) is among the lowest, but South Korea does at least as well spending 30% less per person. Japan, Spain and Italy have longer life expectancy for lower spending.
  • The French model protects the patient. Only 9.3% of health spending is paid directly by households, against 31.8% in Korea and 32.2% in China. Complementary insurers take over from national insurance: the public share (67.7%) is lower than in Germany (79.1%) or Japan (84.8%).
How to read these figures

Spending is in purchasing-power-parity dollars per person: this corrects differences in the general price level between countries, not differences in health prices. That is precisely what shows care is more expensive in the United States. The outcome used by the OECD is treatable mortality: deaths before 75 that timely, high-quality care should have avoided, per 100,000 people, at the same age structure. Life expectancy, a broader measure, also depends heavily on lifestyle and income.

The efficiency frontier links the countries no other country beats on both spending and outcome. A country far from the frontier is not “bad”: it gets a result another country reaches while spending less. The low end of the frontier groups countries that spend little, with average outcomes, simply because none spends less. Above all, this chart is a correlation: diet, tobacco, accidents and income matter too. It raises questions; it does not point to a model to copy.

1. What each country spends

The United States devotes an unmatched share of its wealth to health: 16.7% of GDP of GDP in 2023, against 11.5% of GDP in France. The gap has widened since 2000 (12.5% of GDP against 9.6% of GDP): at constant prices, spending per person grew 99% in the United States and 44% in France.

Current health expenditure, % of GDP

All spending on care and medical goods, public and private, excluding investment (WHO health expenditure database).

  • China
  • South Korea
  • Japan
  • United Kingdom
  • Germany
  • France
  • United States

Source:World Bank / WHO

Show the chart data
PeriodUnited StatesFranceGermanyUnited KingdomJapanSouth KoreaChina
200012.5% of GDP9.6% of GDP9.8% of GDP7.1% of GDP7.0% of GDP3.7% of GDP4.5% of GDP
200113.2% of GDP9.8% of GDP9.8% of GDP7.4% of GDP7.2% of GDP4.2% of GDP4.2% of GDP
200214.0% of GDP10.1% of GDP10.0% of GDP7.9% of GDP7.4% of GDP3.9% of GDP4.3% of GDP
200314.5% of GDP10.1% of GDP10.2% of GDP8.1% of GDP7.5% of GDP4.5% of GDP4.4% of GDP
200414.6% of GDP10.2% of GDP10.0% of GDP8.3% of GDP7.5% of GDP4.4% of GDP4.2% of GDP
200514.6% of GDP10.2% of GDP10.1% of GDP8.4% of GDP7.7% of GDP4.7% of GDP4.1% of GDP
200614.7% of GDP10.4% of GDP10.0% of GDP8.5% of GDP7.7% of GDP5.0% of GDP3.9% of GDP
200714.9% of GDP10.3% of GDP9.8% of GDP8.8% of GDP7.8% of GDP5.0% of GDP3.6% of GDP
200815.2% of GDP10.5% of GDP10.0% of GDP9.0% of GDP8.1% of GDP5.2% of GDP3.8% of GDP
200916.2% of GDP11.3% of GDP11.0% of GDP9.8% of GDP9.0% of GDP5.7% of GDP4.3% of GDP
201016.2% of GDP11.2% of GDP10.8% of GDP9.8% of GDP9.1% of GDP5.8% of GDP4.2% of GDP
201116.1% of GDP11.2% of GDP10.5% of GDP9.8% of GDP10.5% of GDP5.9% of GDP4.3% of GDP
201216.1% of GDP11.3% of GDP10.6% of GDP9.9% of GDP10.7% of GDP6.0% of GDP4.5% of GDP
201316.0% of GDP11.4% of GDP10.7% of GDP10.0% of GDP10.7% of GDP6.1% of GDP4.6% of GDP
201416.1% of GDP11.6% of GDP10.8% of GDP10.0% of GDP10.7% of GDP6.2% of GDP4.7% of GDP
201516.4% of GDP11.5% of GDP10.9% of GDP9.9% of GDP10.7% of GDP6.5% of GDP4.9% of GDP
201616.7% of GDP11.6% of GDP11.0% of GDP9.9% of GDP10.7% of GDP6.6% of GDP4.9% of GDP
201716.6% of GDP11.4% of GDP11.1% of GDP9.7% of GDP10.7% of GDP6.8% of GDP5.0% of GDP
201816.5% of GDP11.3% of GDP11.2% of GDP9.8% of GDP10.7% of GDP7.1% of GDP5.1% of GDP
201916.5% of GDP11.2% of GDP11.4% of GDP10.0% of GDP11.0% of GDP7.7% of GDP5.3% of GDP
202018.5% of GDP12.1% of GDP12.5% of GDP12.1% of GDP11.4% of GDP8.0% of GDP5.5% of GDP
202117.4% of GDP12.2% of GDP12.7% of GDP12.1% of GDP12.1% of GDP8.3% of GDP5.3% of GDP
202216.5% of GDP11.8% of GDP12.4% of GDP11.1% of GDP12.3% of GDP8.9% of GDP5.9% of GDP
202316.7% of GDP11.5% of GDP11.7% of GDP11.0% of GDP10.7% of GDP8.6% of GDP5.9% of GDP
2024–11.5% of GDP12.3% of GDP11.1% of GDP–8.7% of GDP–

Health spending per person, constant prices

2020 purchasing-power-parity dollars, OECD health accounts. The last year may be a provisional estimate.

  • Switzerland
  • South Korea
  • Japan
  • United Kingdom
  • Germany
  • France
  • United States

Source:OECD

Show the chart data
PeriodUnited StatesFranceGermanyUnited KingdomJapanSouth KoreaSwitzerland
2000$6,542$4,252$4,806$2,837$2,792$971$5,035
2001$6,901$4,364$4,859$3,035$2,877$1,114$5,278
2002$7,404$4,547$4,964$3,269$2,919$1,115$5,473
2003$7,802$4,578$5,024$3,442$2,999$1,305$5,573
2004$8,057$4,692$4,971$3,633$3,068$1,351$5,712
2005$8,286$4,759$5,057$3,749$3,159$1,456$5,733
2006$8,517$4,927$5,148$3,855$3,189$1,598$5,688
2007$8,727$5,016$5,247$4,045$3,261$1,692$5,798
2008$8,722$5,077$5,375$4,083$3,300$1,798$5,926
2009$9,056$5,329$5,662$4,226$3,500$1,972$6,133
2010$9,154$5,280$5,783$4,304$3,662$2,153$6,165
2011$9,149$5,324$5,794$4,256$4,196$2,204$6,298
2012$9,281$5,372$5,847$4,374$4,327$2,251$6,502
2013$9,333$5,465$5,942$4,414$4,412$2,355$6,729
2014$9,647$5,542$6,094$4,529$4,448$2,479$6,818
2015$10,099$5,602$6,296$4,631$4,606$2,684$7,053
2016$10,399$5,691$6,453$4,691$4,635$2,850$7,229
2017$10,549$5,725$6,627$4,734$4,695$3,009$7,295
2018$10,774$5,704$6,764$4,806$4,741$3,214$7,285
2019$11,067$5,755$6,987$4,950$4,826$3,478$7,481
2020$12,077$5,770$7,363$5,409$4,859$3,618$7,621
2021$12,007$6,237$7,762$5,837$5,264$3,958$8,026
2022$11,754$6,125$7,675$5,453$5,244$4,220$8,015
2023$12,099$5,937$7,231$5,313$4,960$4,044$7,919
2024$12,551$5,995$7,569$5,496$4,877$4,218$8,037
2025$13,049$6,123$7,907$5,683$4,868$4,259$8,229

2. What each country gets

Each dot is a country: on the left those that spend little, at the bottom those where care prevents the most deaths. Of 36 OECD countries, 9 form the frontier. The United States sits alone, far to the right and high up.

Health spending per person and deaths avoidable through care, OECD countries

Spending: purchasing-power-parity dollars, current prices. Outcome: deaths before 75 avoidable through care, per 100,000 people, age-standardised (lower = better). Each country at its latest year published for both series (2020 – 2023). The dotted line is the efficiency frontier.

  • Efficiency frontier
  • Countries discussed
  • Other countries
Tap or hover over a dot to see which country it is.
501001505,00010,000Spending per person (PPP $)Avoidable deaths per 100,000FranceGermanyJapanSouth KoreaUnited KingdomUnited States

Source:OECD

Show the chart data
CountrySpending per person (PPP $)Avoidable deaths per 100,000PeriodOn the frontier
Mexico$1,377175 per 100,0002022yes
Colombia$1,635115 per 100,0002021yes
Costa Rica$1,75994 per 100,0002022yes
Türkiye$2,103119 per 100,0002023
Chile$3,13078 per 100,0002022yes
Hungary$3,162141 per 100,0002023
Estonia$3,182101 per 100,0002022
Greece$3,24072 per 100,0002022yes
Latvia$3,247154 per 100,0002023
Poland$3,263114 per 100,0002022
Slovakia$3,484130 per 100,0002023
Israel$3,83656 per 100,0002022yes
Lithuania$3,952134 per 100,0002023
Portugal$4,69063 per 100,0002022
South Korea$4,71545 per 100,0002022yes
Italy$4,86552 per 100,0002022
Czechia$4,92187 per 100,0002023
Slovenia$5,20253 per 100,0002023
Spain$5,25150 per 100,0002023
Japan$5,46549 per 100,0002021
United Kingdom$5,82471 per 100,0002021
Finland$5,83457 per 100,0002022
Iceland$6,13849 per 100,0002022
Belgium$6,54950 per 100,0002021
France$6,76148 per 100,0002022
Ireland$6,86457 per 100,0002022
Denmark$6,88855 per 100,0002022
Canada$6,91058 per 100,0002022
Germany$7,36366 per 100,0002020
Australia$7,57447 per 100,0002023
Sweden$7,65547 per 100,0002023
Luxembourg$7,73639 per 100,0002023yes
Netherlands$8,15149 per 100,0002023
Austria$8,27854 per 100,0002023
Switzerland$9,24634 per 100,0002023yes
United States$13,06295 per 100,0002022

Health spending per person and life expectancy, OECD and large emerging countries

Spending: purchasing-power-parity international dollars (WHO, via the World Bank). Outcome: life expectancy at birth (higher = better), which also depends on lifestyle and income. 47 countries, latest year published (2023 – 2024).

  • Efficiency frontier
  • Countries discussed
  • Other countries
Tap or hover over a dot to see which country it is.
7075808505,00010,000Spending per person (PPP $)Life expectancy (years)FranceGermanyJapanSouth KoreaUnited KingdomUnited StatesChina

Source:World Bank / WHO·World Bank

Show the chart data
CountrySpending per person (PPP $)Life expectancy (years)PeriodOn the frontier
India$34672.0 years2023yes
Indonesia$41771.1 years2023
South Africa$1,35466.1 years2023
Mexico$1,36875.1 years2023yes
China$1,48778.0 years2023yes
Colombia$1,75877.9 years2024
Türkiye$1,76977.2 years2023
Costa Rica$1,92880.8 years2023yes
Brazil$2,07075.8 years2023
Hungary$2,87576.6 years2023
Latvia$3,03475.4 years2023
Argentina$3,08977.4 years2023
Russia$3,20473.3 years2023
Slovakia$3,23078.1 years2023
Greece$3,45481.7 years2023yes
Saudi Arabia$3,47578.7 years2023
Chile$3,61281.4 years2024
Estonia$3,74179.3 years2024
Poland$3,93978.4 years2024
Israel$4,03383.2 years2023yes
Lithuania$4,12777.2 years2024
Czechia$4,67480.0 years2024
Portugal$4,92882.4 years2024
Spain$4,93583.9 years2023yes
Italy$4,99384.0 years2024yes
South Korea$5,08183.6 years2024
Japan$5,36584.0 years2023yes
Slovenia$5,42582.3 years2024
New Zealand$5,57682.0 years2024
Finland$6,43381.6 years2023
Singapore$6,55183.1 years2023
United Kingdom$6,60681.4 years2024
France$6,86883.0 years2024
Iceland$6,92782.8 years2024
Denmark$7,26282.3 years2024
Belgium$7,48982.4 years2023
Canada$7,64682.1 years2024
Australia$7,69183.1 years2023
Sweden$7,77084.1 years2024yes
Netherlands$8,19582.0 years2024
Austria$8,25082.0 years2024
Ireland$8,77283.0 years2024
Luxembourg$8,80883.2 years2024
Germany$8,82680.8 years2024
Norway$9,52383.0 years2023
Switzerland$10,60284.2 years2023yes
United States$13,47378.4 years2023
  • 30%Less spending needed to do at least as well as Francetreatable mortality, cheapest OECD country at least as good (here South Korea, $4,715 per person)

    Source:OECD

  • 87%Same calculation for the United Statesan outcome at least as good is observed elsewhere for a fraction of US spending

    Source:OECD

3. Why the United States spends so much

Health accounts track two items where the price argument is most often made: medicines, and running health insurance (costs of public and private insurers, administration of the system).

Spending on medicines and other non-durable medical goods, per person

Purchasing-power-parity dollars, current prices (health accounts item HC51).

  • Switzerland
  • South Korea
  • Japan
  • United Kingdom
  • Germany
  • France
  • United States

Source:OECD

Show the chart data
PeriodUnited StatesFranceGermanyUnited KingdomJapanSouth KoreaSwitzerland
2010$986$614$663–$649$462$605
2011$1,004$617$652–$707$473$613
2012$1,013$620$671–$750$478$642
2013$1,020$637$694$436$812$466$675
2014$1,118$641$740$448$814$471$688
2015$1,189$631$761$451$891$509$712
2016$1,193$656$819$468$797$545$755
2017$1,202$658$850$473$805$565$770
2018$1,224$653$892$463$809$607$794
2019$1,268$682$937$489$835$651$863
2020$1,328$697$1,017$553$848$724$896
2021$1,422$716$1,144$545$887$752$963
2022$1,515$786$1,188$615$932$864$1,085
2023$1,652$812$1,227$629$1,026$925$1,067
2024$1,752$851$1,338$635$1,029$1,000$1,193
2025–$854–––$1,004–

Cost of governing and financing the health system, per person

Purchasing-power-parity dollars, current prices (item HC7). Countries do not all classify the same spending under this item: gaps between European countries call for caution.

  • Switzerland
  • South Korea
  • Japan
  • United Kingdom
  • Germany
  • France
  • United States

Source:OECD

Show the chart data
PeriodUnited StatesFranceGermanyUnited KingdomJapanSouth KoreaSwitzerland
2010$585$245$237–$50$53$249
2011$607$253$241–$64$55$253
2012$626$260$244–$65$61$246
2013$653$278$248$86$69$59$248
2014$733$279$247$84$57$66$253
2015$761$277$254$79$74$69$261
2016$797$289$271$74$71$74$280
2017$817$292$278$79$76$80$276
2018$922$295$293$82$79$87$280
2019$887$308$300$91$83$100$303
2020$1,071$316$326$113$70$123$315
2021$974$320$342$104$74$143$337
2022$1,041$343$377$115$86$141$373
2023$1,102$360$394$110$80$138$412
2024$1,094$378$400$114$79$147$433
2025–$388–––$173–

Why the United States spends so much: what the research says

C
Level of evidence C

Several comparative studies agree: Americans do not use more care than Europeans, they pay more for it, and their system costs more to administer. These are comparisons of data, not experiments: the finding is solid, while the causal link with a given rule (price negotiation, single payer) remains to be established.

  • C
    Anderson, Reinhardt, Hussey and Petrosyan (2003), Health Affairs, “It’s The Prices, Stupid”Method: comparison of spending and use of care across OECD countries

    The US spending gap is caused mostly by higher prices for health care goods and services, not by greater use of care.

  • C
    Anderson, Hussey and Petrosyan (2019), Health Affairs, “It’s Still The Prices, Stupid”Method: update of the same comparison on more recent data

    Fifteen years later the chief reason is the same: not greater use of care, but higher prices.

  • C
    Papanicolas, Woskie and Jha (2018), JAMAMethod: comparison of the United States with ten other high-income countries on about a hundred spending, utilisation and price indicators

    Americans have fewer physician visits and fewer hospital days; the extra cost comes from administrative complexity and high prices across a wide range of care, including drugs and health workers’ pay.

The scale
  • A: causal effect shown by several studies with a rigorous design (experiment, reform compared with a control group), in several countries.
  • B: causal effect shown by at least one rigorous study, or several quasi-experimental studies that agree.
  • C: strong correlations and a plausible mechanism, no causal proof.
  • D: descriptive observation or expert opinion only.

4. Who pays: the patient, insurance or taxes

The French model combines compulsory national insurance and complementary insurance, so patients pay very little out of pocket. In Asia, South Korea and China leave a much larger share to households.

Share of health spending paid directly by households

Out-of-pocket payments after reimbursement, % of current health expenditure.

  • China
  • South Korea
  • Japan
  • United Kingdom
  • Germany
  • France
  • United States

Source:World Bank / WHO

Show the chart data
PeriodUnited StatesFranceGermanyUnited KingdomJapanSouth KoreaChina
200015.1%7.3%11.8%18.2%15.9%43.3%60.1%
200114.4%7.3%11.8%18.0%15.8%41.3%64.2%
200214.3%7.1%12.0%17.4%16.0%40.8%62.9%
200314.2%7.4%12.3%16.2%16.9%45.2%60.7%
200414.0%7.2%13.5%14.7%16.6%44.8%58.8%
200513.9%7.4%13.6%13.4%15.7%44.4%57.7%
200613.7%9.4%13.9%12.4%16.4%42.5%56.0%
200713.6%9.5%13.8%14.4%15.5%40.6%51.3%
200813.4%10.0%13.5%13.5%15.2%41.6%47.4%
200912.6%10.2%13.3%12.4%15.2%39.2%43.5%
201012.4%11.4%13.3%13.2%14.6%38.8%40.8%
201112.3%11.5%13.3%13.3%13.1%39.0%40.3%
201212.3%11.3%13.5%14.2%13.0%38.7%39.2%
201312.3%10.2%12.7%15.8%12.7%38.3%38.2%
201412.0%11.1%12.4%15.7%12.9%37.6%36.6%
201511.8%11.0%12.4%15.9%12.9%37.7%35.1%
201611.6%10.7%12.2%15.7%12.9%36.5%35.9%
201711.3%10.6%12.0%15.8%12.7%35.8%36.1%
201811.3%10.4%12.2%16.2%13.0%34.7%35.8%
201911.3%10.3%12.4%16.0%12.9%32.8%35.2%
202010.1%9.4%11.3%12.4%11.6%31.8%34.8%
202110.7%9.2%11.4%13.0%10.8%29.7%34.4%
202211.0%9.2%10.4%14.4%11.1%29.3%31.6%
202310.9%9.3%11.1%14.6%12.2%31.8%32.2%
2024–9.2%10.7%14.6%–33.7%–

Share of health spending financed by government

Central and local government and social security, % of current health expenditure. In France, complementary insurers (mutual funds, insurance companies) are not counted here.

  • China
  • South Korea
  • Japan
  • United Kingdom
  • Germany
  • France
  • United States

Source:World Bank / WHO

Show the chart data
PeriodUnited StatesFranceGermanyUnited KingdomJapanSouth KoreaChina
200044.4%72.7%78.5%75.8%80.4%50.6%22.0%
200145.3%72.8%78.5%75.9%81.0%54.2%22.9%
200245.2%73.0%78.1%76.8%80.8%54.8%25.4%
200345.0%72.6%77.8%78.3%80.0%50.3%28.4%
200445.4%72.6%76.2%80.2%80.3%50.8%30.2%
200545.5%72.5%76.0%81.3%81.2%51.2%32.8%
200646.3%71.3%75.6%82.4%80.3%53.1%35.1%
200746.3%71.1%75.6%80.4%81.2%54.9%39.0%
200847.5%70.6%75.7%81.3%81.2%53.4%44.5%
200948.6%70.7%76.0%82.7%81.3%55.0%49.4%
201049.0%69.6%76.1%82.0%81.9%55.3%51.9%
201149.1%69.5%75.8%81.8%83.7%54.5%53.7%
201248.8%69.6%75.8%81.0%83.9%54.3%55.7%
201349.5%70.2%76.8%79.5%84.3%54.7%57.1%
201450.8%69.8%77.4%79.6%84.1%54.5%58.4%
201551.4%71.6%77.4%79.5%84.1%54.3%60.2%
201651.3%74.4%77.8%80.1%84.0%55.0%58.1%
201751.3%75.2%78.1%79.7%84.2%55.7%56.7%
201851.6%75.2%77.9%79.4%83.8%56.5%56.4%
201952.0%74.6%77.9%79.7%84.0%57.6%56.0%
202056.9%76.3%79.2%84.1%85.4%58.2%54.7%
202155.5%75.5%79.6%83.7%86.3%60.8%54.1%
202255.2%75.3%80.5%82.1%86.0%62.3%57.7%
202354.0%67.7%79.1%81.8%84.8%58.6%57.1%
2024–68.4%–––56.6%–

5. Is the French model efficient?

Compared with the United States, without a doubt: France spends half as much per person, with treatable mortality half as high and one of the lowest out-of-pocket shares in the world. Compared with Germany, it gets better results (66 per 100,000 avoidable deaths per 100,000 in 2020) for slightly lower spending ($7,363).

But it is not on the frontier. South Korea, Japan, Spain and Italy get comparable results for less; with the broader measure of life expectancy, an outcome at least as good is observed elsewhere for 41% less spending. And administration is not its strength: it costs $378 per person in France, as in Germany ($400), against $79 in Japan, which partly reflects the coexistence of national and complementary insurance.

That social security’s pressure on prices explains this position remains a plausible hypothesis, not an established fact: the data show lower prices than in the United States, they do not allow attributing them to a specific rule (evidence level D for this claim).

What we know, what we don’t

What the figures establish

  • The United States spends by far the most per person, for worse outcomes than most rich countries.
  • Its extra cost comes mostly from prices and administration, not from using more care (comparative studies agree).
  • France strongly protects patients: its out-of-pocket share is among the lowest.

What they don’t tell

  • How much of the outcome gaps comes from the health system rather than lifestyle, income or diet.
  • Whether price regulation by national insurance causes France’s relative efficiency.
  • Whether low-spending Asian countries can keep it up as their populations age fast.

Stay up to date

This deep dive is updated at least once a quarter with the new figures. Follow it to get a notification at each update.

Sources

Series downloaded from their producers on Nov 14, 2026, the snapshot date. Only published periods are used: no projection.

  • OECD Health expenditure and financing (System of Health Accounts), DSD_SHA@DF_SHA
  • OECD Avoidable mortality (treatable and preventable), DSD_HEALTH_STAT@DF_AM
  • World Bank Life expectancy at birth, total (years), SP.DYN.LE00.IN
  • World Bank / WHO Current health expenditure per capita, PPP (current international $), SH.XPD.CHEX.PP.CD
  • World Bank / WHO Current health expenditure (% of GDP), SH.XPD.CHEX.GD.ZS
  • World Bank / WHO Out-of-pocket expenditure (% of current health expenditure), SH.XPD.OOPC.CH.ZS
  • World Bank / WHO Domestic general government health expenditure (% of current health expenditure), SH.XPD.GHED.CH.ZS